Development and validation of a low-cost, open-source robotic extrusion printing platform for acellular hydrogel scaffold fabrication: A step toward multi-axis robotic bioprinting
International Journal of Bioprinting · 18.11.2026 · 026330352
DOI: 10.36922/ijb026330352 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Bioprinting, online erschienen am 18.11.2026. Verfasst von Kenneth Houston und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Commercial multi-axis robotic bioprinting platforms remain prohibitively expensive for many laboratories, limiting access to robot-assisted biofabrication. This study converted a low-cost six-axis industrial robot (ABB IRB 120T with IRC5 Compact controller) into an open-source robotic extrusion printing platform and compared its dimensional performance with a commercial robotic bioprinter (BioAssemblyBot 400). Validation was limited to acellular hydrogel and planar toolpaths; cell-laden and non-planar printing remain necessary for biological validation. The platform integrated a modified printhead, elevated glass print bed, solenoid-based extrusion control, and a software pipeline that translated slicer-generated G-code into ABB RAPID motion and I/O commands. Five scaffolds were printed using the developed platform and three using the commercial system with a 4% alginate–4% carboxymethylcellulose bioink. The retrofitted platform demonstrated higher repeatability, with a mean coefficient of variation of 2.25% and maximum dimensional range of 0.388 mm, compared with 5.07% and 1.130 mm for the commercial system. Scaffold-level analysis (n = 5 vs. n = 3) showed significantly lower macro-scale dimensional variance for the retrofitted system, while pore-scale variance was lower but not statistically significant. No statistically significant difference between platforms was detected for overall-dimension or Y-direction pore-width accuracy, whereas the retrofitted system showed better X-direction pore-length accuracy in the pooled analysis. The total development cost was $16,617, an 89.6% reduction relative to the commercial system. These findings demonstrate a technically viable, substantially lower-cost pathway to multi-axis robotic biofabrication, with remaining dimensional limitations likely tied to bioink processing and the absence of crosslinking rather than robotic motion control.
Zitieren
APA
Houston, K., Woods, P., & Habib, A. (2026). Development and validation of a low-cost, open-source robotic extrusion printing platform for acellular hydrogel scaffold fabrication: A step toward multi-axis robotic bioprinting. International Journal of Bioprinting, 0(0), 026330352. https://doi.org/10.36922/ijb026330352
Vancouver
Houston K, Woods P, Habib A. Development and validation of a low-cost, open-source robotic extrusion printing platform for acellular hydrogel scaffold fabrication: A step toward multi-axis robotic bioprinting. International Journal of Bioprinting. 2026;0(0):026330352. doi:10.36922/ijb026330352
BibTeX
@article{Houston2026,
author = {Houston, Kenneth and Woods, Perrin and Habib, Ahasan},
title = {Development and validation of a low-cost, open-source robotic extrusion printing platform for acellular hydrogel scaffold fabrication: A step toward multi-axis robotic bioprinting},
journal = {International Journal of Bioprinting},
year = {2026},
volume = {0},
number = {0},
pages = {026330352},
doi = {10.36922/ijb026330352}
}
EUVIMED